DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-429 Cr | ₹-974 Cr | ₹-629 Cr | ₹-1,276 Cr | ₹-1,040 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of DR REDDYS LABORATORIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-429 Cr |
| Mar2024 | ₹-974 Cr |
| Mar2023 | ₹-629 Cr |
| Mar2022 | ₹-1,276 Cr |
| Mar2021 | ₹-1,040 Cr |
How is Deferred Tax Assets / Liabilities of DR REDDYS LABORATORIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-429 Cr | Negative | |
| Mar2024 | ₹-974 Cr | Negative | |
| Mar2023 | ₹-629 Cr | Negative | |
| Mar2022 | ₹-1,276 Cr | Negative | |
| Mar2021 | ₹-1,040 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹104,333.3 Cr | 1.2% | 0.3% | -1.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,077.0 Cr | 1.6% | 6% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,324.0 Cr | -0.7% | -1.9% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹126,235.0 Cr | -0.8% | 7.4% | 21.2% | Stock Analytics | |
| CIPLA | ₹123,294.0 Cr | -0.4% | -3.4% | 0.8% | Stock Analytics | |
| MANKIND PHARMA | ₹91,762.4 Cr | -2.2% | -9.4% | -14.6% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 1.2% |
0.3% |
-1.5% |
| SENSEX | 0.9% |
2.1% |
8.3% |
You may also like the below Video Courses